Production (Stage)
Castle Biosciences, Inc.
CSTL
$16.10
$0.211.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.85M | 9.59M | 2.27M | 8.92M | -2.53M |
| Total Depreciation and Amortization | 29.76M | 5.77M | 3.54M | 3.35M | 3.34M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.43M | 7.02M | 16.75M | 9.82M | 11.16M |
| Change in Net Operating Assets | -20.38M | 1.98M | 776.00K | 1.91M | -18.80M |
| Cash from Operations | -6.04M | 24.37M | 23.34M | 24.00M | -6.84M |
| Capital Expenditure | -4.74M | -7.57M | -6.38M | -5.23M | -9.15M |
| Sale of Property, Plant, and Equipment | 9.00K | 7.00K | 4.00K | 2.00K | 5.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.70M | 13.33M | -8.42M | -16.19M | -10.55M |
| Cash from Investing | -22.43M | 5.77M | -14.79M | -21.42M | -19.70M |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 10.00M |
| Total Debt Repaid | -26.00K | -26.00K | -24.00K | -11.00K | -36.00K |
| Issuance of Common Stock | 988.00K | 1.02M | 2.16M | 668.00K | 1.15M |
| Repurchase of Common Stock | -2.52M | -6.38M | -1.29M | -615.00K | -474.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.55M | -5.39M | 838.00K | 42.00K | 10.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.02M | 24.75M | 9.39M | 2.62M | -15.89M |